Biotech

All Articles

Less than a year in, BenevolentAI CEO is actually out-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of substantial management hirings, shootings...

Roche MAGE-A4 trial withdrawn after tactical customer review

.Roche has actually created one more MAGE-A4 program go away, withdrawing a period 1 trial of a T-ce...

FDA puts partial hold on BioNTech-OncoC4 period 3 test

.The FDA has actually carried out a partial hold on a period 3 non-small cell bronchi cancer trial r...

REGiMMUNE, Kiji combine to make Treg 'super provider,' plan IPO

.Taiwan's REGiMMUNE and Europe-based Kiji Therapeutics are actually merging to produce an around the...

With test gain, Merck wants to take on Sanofi, AZ in RSV

.3 months after exposing that its breathing syncytial infection (RSV) preventive antibody clesrovima...

Noema ticks off period 2a Tourette gain for ex-Roche molecule

.Noema Pharma has actually scored a phase 2a succeed for its own Tourette disorder medication prospe...

Terray puts together $120M set B to innovation AI-powered particles

.Terray Therapies has actually brought in $120 thousand for a set B fundraise as the AI-focused biot...

Kezar declines Concentra buyout that 'underestimates' the biotech

.Kezar Life Sciences has ended up being the latest biotech to choose that it could come back than a ...

Wave addresses individual RNA editing and enhancing first for GSK-partnered possibility

.Surge Life Sciences has taken a measure towards legitimizing a brand new modality, becoming the ver...

Chinese the hormone insulin creator's GLP-1 tops Ozempic in ph. 2

.Chinese the hormone insulin maker Gan &amp Lee Pharmaceuticals is wading into the excessive weight ...